BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23497265)

  • 21. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
    Wu ZS; Wu Q; Wang CQ; Wang XN; Wang Y; Zhao JJ; Mao SS; Zhang GH; Zhang N; Xu XC
    BMC Cancer; 2010 Oct; 10():542. PubMed ID: 20932331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
    Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
    Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F.
    Jurmeister S; Baumann M; Balwierz A; Keklikoglou I; Ward A; Uhlmann S; Zhang JD; Wiemann S; Sahin Ö
    Mol Cell Biol; 2012 Feb; 32(3):633-51. PubMed ID: 22144583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis.
    Li Y; Zhang M; Chen H; Dong Z; Ganapathy V; Thangaraju M; Huang S
    Cancer Res; 2010 Oct; 70(20):7894-904. PubMed ID: 20736365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
    Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
    Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dectection and analysis of miRNA expression in breast cancer-associated fibroblasts].
    Zeng Z; Hu P; Tang X; Zhang H; Du Y; Wen S; Liu M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1071-5. PubMed ID: 25270211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
    Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1.
    Sun Q; Liu T; Yuan Y; Guo Z; Xie G; Du S; Lin X; Xu Z; Liu M; Wang W; Yuan Q; Chen L
    Int J Cancer; 2015 Mar; 136(5):1003-12. PubMed ID: 25044403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
    Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
    Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z
    Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory network reconstruction of five essential microRNAs for survival analysis in breast cancer by integrating miRNA and mRNA expression datasets.
    He K; Li WX; Guan D; Gong M; Ye S; Fang Z; Huang JF; Lu A
    Funct Integr Genomics; 2019 Jul; 19(4):645-658. PubMed ID: 30859354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
    Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
    Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.
    Chen ML; Liang LS; Wang XK
    Clin Exp Metastasis; 2012 Jun; 29(5):457-69. PubMed ID: 22407310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
    Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
    J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of miR-200c on the proliferation, migration and invasion of breast cancer cells and relevant mechanisms.
    Yuan X; Liu J; Ye X
    J BUON; 2019; 24(1):61-67. PubMed ID: 30941952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.
    Zhao L; Sun Y; Hou Y; Peng Q; Wang L; Luo H; Tang X; Zeng Z; Liu M
    Int J Biochem Cell Biol; 2012 Nov; 44(11):2051-9. PubMed ID: 22964023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.